Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Use of Second-Trimester Genetic Sonogram in Guiding Clinical Management of Patients at Increased Risk for Fetal Trisomy 21

1 Jun 1996

Abstract excerpt

OBJECTIVE: To test the efficacy of ultrasound in detecting fetuses with trisomy 21. METHODS: From November 1, 1992, to December 31, 1995, a second-trimester genetic sonogram was offered to all women with singleton fetuses at increased risk (at least 1:274) for trisomy 21, who had either declined genetic amniocentesis or chose to have a sonogram before deciding whether to undergo an amniocentesis. In addition to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Assisted Reproductive Technology and Twin Pregnancy
Share to Fetal and Pediatric Neurological Disorders
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 8649704
DOI: 10.1016/0029-7844(96)00053-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Use of Second-Trimester Genetic Sonogram in Guiding Clinical Management of Patients at Increased Risk for Fetal Trisomy 21PMID 8649704Read ↗

Trisomy 21: 91% detection rate using second‐trimester ultrasound markersSemantic proximity Read ↗

Use of the genetic sonogram in the United States in 2001 and 2007.Semantic proximity Read ↗

Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of Trisomy 18 based on serum screeningSemantic proximity Read ↗

UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.Semantic proximity Read ↗

First-Trimester Screening for Trisomies 21 and 18Semantic proximity Read ↗

The second trimester genetic sonogramSemantic proximity Read ↗

Prospective ranking of the sonographic markers for aneuploidy: Data of 2143 prenatal cytogenetic diagnoses referred for abnormalities on ultrasoundSemantic proximity Read ↗

Prenatal screening for trisomy 21: recent advances and guidelinesSemantic proximity Read ↗

Prenatal Detection of Fetal Trisomy 18 Through Abnormal Sonographic FeaturesSemantic proximity Read ↗

Second trimester ultrasound screening for chromosomal abnormalitiesSemantic proximity Read ↗

Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimesterSemantic proximity Read ↗

First trimester combined screening for fetal aneuploidies enhanced with additional ultrasound markers: an 8-year prospective study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.